The officer directed authorities to shut down the medical store in Bhakshya Suraksha market, which started functioning on March 21. The District Election Officer (DEO) here on Monday directed the Twenty20 Association, linked with the Twenty20 political party run by business group Kitex, to shut down a recently opened medical shop offering substantial discounts,… Continue reading Election officer shuts Twenty20 pharma shop in Kerala for MCC violation | Lok Sabha Elections News
Tag: Pharma
Gland Pharma posts 41% jump in quarterly revenue on Cenexi acquisition
HYDERABAD (Reuters) – Indian generic injectables maker Gland Pharma Ltd reported a 41% jump in first-quarter revenue on Monday, aided by its acquisition of French pharmaceutical group Cenexi. The Hyderabad-based company, which draws the bulk of its revenue from the United States, Europe, Canada, Australia and New Zealand, said revenue jumped to 12.09… Continue reading Gland Pharma posts 41% jump in quarterly revenue on Cenexi acquisition
Aurobindo Pharma hits 2-year high; stock zooms 100% thus far in 2023
Shares of Aurobindo Pharma hit a two-year high of Rs 872.95, as they gained 4 per cent on the BSE in Monday’s intra-day trade after the company got US drug regulator’s approval for skin and bone infection drug. The stock was trading at its highest level since August 2021. Thus far in calendar year 2023,… Continue reading Aurobindo Pharma hits 2-year high; stock zooms 100% thus far in 2023
USFDA issues warning letter to Intas Pharma for lapses at Sanand plant
The US health regulator has pulled up Intas Pharmaceuticals for manufacturing lapses, including failure of its quality control unit to ensure CGMP compliance, at its Sanand-based manufacturing plant. In a warning letter dated July 28, 2023, the US Food and Drug Administration (USFDA) pointed out various manufacturing lapses at the plant. “This… Continue reading USFDA issues warning letter to Intas Pharma for lapses at Sanand plant
Centre extends deadline for track and trace system for pharma exports
The Directorate General of Foreign Trade (DGFT) has extended the deadline for implementing the Track and Trace system for pharmaceutical and drug exports until 1 February 2024. The extension applies to both Small Scale Industries (SSI) and non-SSI manufactured drugs. This move follows a series of notifications intended to establish a procedural framework… Continue reading Centre extends deadline for track and trace system for pharma exports
Alembic Pharma Q1 consolidated profit rose to $14.6 mn on strong sales
Revenue from its India business rose 9%, while its U.S. business rose 6%. BENGALURU (Reuters) – Indian drugmaker Alembic Pharmaceuticals posted first-quarter profit on Friday, boosted by strong sales in its domestic and U.S. markets. The Vadodara-based company said consolidated profit rose to 1.21 billion rupees ($14.6 million) for the quarter ended June… Continue reading Alembic Pharma Q1 consolidated profit rose to $14.6 mn on strong sales
Sun Pharma Q1 PAT dips 2% on one-time expense; US revenues up 12%
Sun Pharmaceutical Industries posted a near 2 per cent year-on-year (YoY) decline in profit after tax (PAT) for the first quarter of FY24 to Rs 2,022.5 crore due to a one-time exceptional expense. The firm’s total income grew by almost 13 per cent. The firm’s stock ended flat at Rs 1,140.85 on the… Continue reading Sun Pharma Q1 PAT dips 2% on one-time expense; US revenues up 12%
Nifty Metal to be range-bound; Pharma index bullish with need for caution
Nifty Metal Index: Hourly Charts Signal Range-Bound Trading The Nifty Metal Index (last close: 6633.45) is currently showing signs of range-bound trading based on the hourly charts. The index is likely to oscillate between the levels of 6675 and 6580, with a decisive move above or below these levels expected to trigger significant directional… Continue reading Nifty Metal to be range-bound; Pharma index bullish with need for caution
Mankind Pharma PAT up 66% in Q1 to Rs 494 crore on revenue growth
Mankind Pharma | Photo: Website Delhi-headquartered Mankind Pharma reported a 66 per cent year-on-year (YoY) increase in profit after tax (PAT) for the first quarter (Q1) of 2023-24 (FY24), reaching Rs 494 crore. This surge was supported by an 18 per cent YoY rise in revenue from operations, amounting to Rs 2,579 crore. The… Continue reading Mankind Pharma PAT up 66% in Q1 to Rs 494 crore on revenue growth
Sun Pharma Q1 profit may be weighed by weak US specialty sales and Taro nos
Drugmaker Sun Pharmaceutical Industries (Sun Pharma) is expected to report a muted net profit for the June quarter (Q1FY24) when it announces its earnings on Thursday, August 3. The pressure on earnings is likely due to flat growth for the arm Taro Pharma, weak US generic sales as a result of product restrictions at… Continue reading Sun Pharma Q1 profit may be weighed by weak US specialty sales and Taro nos